<DOC>
	<DOCNO>NCT02937350</DOCNO>
	<brief_summary>The goal study well understand vitamin D catabolism affect CKD race . Specifically , study team evaluate metabolic clearance 25-hydroxyvitamin D3 individual vary degree CKD among participant self-report race Caucasian , African American African . The long-term goal work enhance clinical evaluation treatment impair vitamin D metabolism .</brief_summary>
	<brief_title>Clearance 25-hydroxyvitamin D Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hydroxycholecalciferols</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<criteria>Age â‰¥ 18 year Selfreported race Caucasian , African American , African Serum total 25 ( OH ) D 1050 ng/mL Estimated GFR : 60 mL/min/1.73m2 ( N=40 ) 1545 mL/min/1.73m2 ( N=40 ) &lt; 15 mL/min/1.73m2 , treat hemodialysis ( N=40 ) Primary hyperparathyroidism Gastric bypass Tuberculosis sarcoidosis Current pregnancy ChildPugh Class B C cirrhosis ( i.e . cirrhosis ascites , hepatic encephalopathy , bilirubin &gt; =2 mg/dL , serum albumin &lt; =3.5 g/dL , PT &gt; = 4 second ) Use vitamin D3 , vitamin D2 supplement exceed mean daily dose 400 IU , within 3 month ( washout allow ) Use 1,25 ( OH ) 2D3 analogue , calcimimetics , medication know induce CYP24A1 within 4 week ( washout allow ) Serum calcium &gt; 10.1 mg/dL Hemoglobin &lt; 10 g/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>chronic kidney disease</keyword>
	<keyword>vitamin catabolism</keyword>
</DOC>